Nitrile Gloves, Not Ribbons

Every October, the noise starts up again: it’s breast cancer’s turn for awareness. I brace for it a little every year. What bothers me isn’t the concept, it’s watching companies race to out-pink each other.

A pink ribbon on a shirt or a car can foster a certain amount of solidarity, but at the corporate level, the awareness noise is genuinely inescapable: a building lit up pink for the night, a pink yogurt lid, or a player running out onto the field in pink cleats. Many companies have run some version of the same campaign, and what actually happens to the profit from pink merchandise varies wildly: modest percentages, hard caps on total donations, or numbers that only recently moved after enough people asked questions.

In addition to the question of money is the question of effect: what does a company’s participation do? If the goal actually is awareness, I’ve never understood who remains unaware. It tends to generate goodwill instead, and the sometimes cynical among us might call that marketing, whether or not that’s the intent.

Here’s a sentence that’s true to me, one most people have their own version of: my sister had breast cancer. One in eight women in the U.S. will hear that diagnosis in her lifetime (though women aren’t the only ones who get it). So we are aware. We have been aware for a long time.

At one point, however, we actually needed awareness, in the literal sense of the word. When the American Cancer Society started its breast cancer awareness campaign in 1985, breast cancer was a disease people didn’t discuss in polite company, self-exams weren’t routine, and mammograms weren’t the norm they are now. Getting people to talk about it, check themselves, and get screened was a real, specific goal, and awareness did its job at the time. Last year marked the campaign’s fortieth anniversary, a point at which even the American Cancer Society’s own retrospective pointedly admitted: awareness alone isn’t enough anymore.

October runs on that word, awareness, as if noticing something were the same as solving it. As if on November 1st, we can dust off our hands, congratulate ourselves, and move on to the next color of the month. But breast cancer research doesn’t run on that calendar. Real, promising work has been happening. Learning about it might not change anything either, not directly, but it’s one step closer to what the American Cancer Society itself is now calling “Turning Awareness Into Action.”

More Than a Pretty Face

This starts, perhaps unexpectedly, with the axolotl, a foot-long Mexican salamander known for its perpetual smile and the feathery gills that fan out from its head like a spray of coral. The most common pet-store variety is also, conveniently for this piece, pale pink. It has become plastered across backpacks, folders, plush toys, and t-shirts. My nine-year-old niece and her friends are obsessed with them.

Continue reading “Nitrile Gloves, Not Ribbons”

The Hidden Costs of “Good Enough” Extraction

The translational oncology landscape has changed dramatically in the past two decades, and with it, the demands on the laboratories doing this work. Today’s translational oncology workflows require DNA and RNA from the same FFPE tissue section, cell-free DNA from large plasma volumes, and nucleic acids from heterogeneous batches of sample types processed in a single run. The analyte diversity has increased dramatically, and at the same time, the downstream assays interrogating those samples have grown more sensitive. The operational pressures have grown alongside the scientific ones. Labs are processing more samples than ever, but not with proportionally more staff. Same-day extraction to analysis is increasingly the expectation, not the exception. All of that change and complexity lands at the extraction step first.

Scientist holding up an FFPE tissue sample. Such samples are vital for nucleic acid extraction required for retroactive studies.

Extraction has long been treated as the step before the experiment, the part you complete before the real work begins. However, as these pressures on the translational laboratory grow, overlooking potential issues with extraction could be disastrous, particularly for labs working with limited, irreplaceable samples, because pre-analytical variability at the extraction step propagates through every downstream process. When extraction is overlooked, information in a sample can be lost and with it the insight into the biological question your downstream assay is asking.

Continue reading “The Hidden Costs of “Good Enough” Extraction”

CRISPR/Cas9 Knock-In Tagging: Simplifying the Study of Endogenous Biology

Understanding the expression, function and dynamics of proteins in their native environment is a fundamental goal thatโ€™s common to diverse aspects of molecular and cell biology. To study a protein, it must first be labeledโ€”either directly or indirectlyโ€”with a โ€œtagโ€ that allows specific and sensitive detection.

Using a labeled antibody to the protein of interest is a common method to study native proteins. However, antibody-based assays, such as ELISAs and Western blots, are not suitable for use in live cells. These techniques are also limited by throughput and sensitivity. Further, suitable antibodies may not be available for the target protein of interest.

Continue reading “CRISPR/Cas9 Knock-In Tagging: Simplifying the Study of Endogenous Biology”

Base Editing Brilliance: David Liuโ€™s Breakthrough Prize and Its Impact

On April 5, 2025, Dr. David R. Liu stood in the spotlight at the Barker Hangar in Santa Monica, California, to receive the Breakthrough Prize in Life Sciencesโ€”one of the most prestigious honors in science.
Dubbed the “Oscars of Science,” the Breakthrough Prizes were launched in 2012 by tech philanthropists including Sergey Brin, Mark Zuckerberg and Priscilla Chan, Yuri and Julia Milner and Anne Wojcicki. These prizes recognize groundbreaking achievements in life sciences, physics, and mathematics, with each laureate receiving a $3 million awardโ€”more than twice the amount of a Nobel Prize.

The winners are selected by panels of previous Breakthrough Prize recipients, ensuring peer-driven recognition. The annual ceremony brings together not only the best minds in science but also celebrities, filmmakers, and tech industry leaders, creating an uncommon crossover between pop culture and research, in an effort to bring more public attention as well as funding to scientific achievement.

Dr. Liu was honored for inventing base editing and prime editing, technologies that allow precise, programmable rewriting of DNA to correct mutations linked to genetic diseaseโ€”without introducing double-stranded breaks. These tools have rapidly transitioned from the bench to the clinic, with at least 15 clinical trials currently underway worldwide targeting diseases like sickle cell anemia, T-cell leukemia, and others.

Continue reading “Base Editing Brilliance: David Liuโ€™s Breakthrough Prize and Its Impact”

The Buzz on Biodiversity: Exploring Pollinator Diversity Through Mitochondrial DNA Analysis

Almost three-quarters of the major crop plants across the globe depend on some kind of pollinator activity, and over one-third of the worldwide crop production is affected by bees, birds, bats, and other pollinators such as beetles, moths and butterflies (1). The economic impact of pollinators is tremendous: Between $235โ€“577 billion dollars of global annual food production relies on the activity of pollinators (2).  Nearly 200,000 species of animals act as pollinators, including some 20,000 species of bees (1). Some of the relationships between pollinators and their target plants are highly specific, like that between fig plants and the wasps that pollinate them. Female fig wasps pollinate the flowers of fig plants while laying their eggs in the flower. The hatched wasp larvae feed on some, but not all, of the seeds produced by fertilization. Most of the 700 fig plants known are each pollinated by only one or a few specific wasp species (3). These complex relationships are one reason pollinator diversity is critical.

Measuring the Success of Conservation Legislation

A bee pollinates flowers in a field. Pollinator diversity is a critical aspect of ecosystems.
A bee pollinates the lavender flowers.

We are now beginning to recognize how critical pollinator diversity is to our own survival, and many governments, from the local level to the national level are enacting policies and legislation to help protect endangered or threatened pollinator species. However, ecosystems and biodiversity are complex subjects that make measuring and attributing meaningful progress on conservation difficult. Not only are there multiple variables in every instance, but determining the baseline starting point before the legislation is difficult. However, there are dramatic examples of success in saving species through legislative and regulatory action. The recovery of the bald eagle and other raptor populations in the United States after banning the use of DDT is one such example (4).

Continue reading “The Buzz on Biodiversity: Exploring Pollinator Diversity Through Mitochondrial DNA Analysis”

Streamlining Plant Pathogen Detection: Valto Biocontrolโ€™s Integration of Promega High-Throughput Nucleic Acid Extraction Platform

This review summarizes Valto Biocontrolโ€™s move toward a high-throughput (HT) nucleic acid extraction solution utilizing Promega Maxwellยฎ HT simplyRNA Kit, Custom. This project was initiated by Dr. Menno Westerdijk, Head of Laboratories at Valto Biocontrol, who established a molecular laboratory onsite. The Promega Field Support Scientist team assisted Dr. Westerdijk to develop an automated nucleic acid solution using their existing KingFisher™ Flex robot. Dr. Westerdijk’s extensive experience working with KingFisher robots in the agricultural sector combined with expert guidance from Promega Field Support enabled a seamless implementation of the Maxwellยฎ HT chemistry for his laboratory.

Continue reading “Streamlining Plant Pathogen Detection: Valto Biocontrolโ€™s Integration of Promega High-Throughput Nucleic Acid Extraction Platform”

Our Maxwellยฎ Travels from Spain to Antarctica to Help Stop the Avian Flu Virus

In January 2024, Antonio Alcamรญ and รngela Vรกzquez, virologists from the Severo Ochoa Centre for Molecular Biology, landed in Antarctica to study the avian flu virus. They embarked on a journey to monitor 17,000 penguins as part of their efforts to study the virus and prevent its spread. Our Maxwellยฎ RSC 48 was delivered to extract nucleic acids from the samples, which are set to be analyzed using qPCR.

Continue reading “Our Maxwellยฎ Travels from Spain to Antarctica to Help Stop the Avian Flu Virus”

Automated Sampling and Detection of ToBRFV: An Emerging Tomato Virusย 

Tomatoes affected by a virus, showing the yellow and brown spots characteristic of ToBRFV.

In the Spring of 2015, greenhouse tomato plants grown in Jordan presented with a mosaic pattern of light and dark green patches on leaves, narrowing leaves, and yellow- and brown-spotted fruit (Salem et al. 2016). The pathogen was identified as a novel plant virus, the tomato brown rugose fruit virus (ToBRFV), and the original outbreak was traced back to the fall of 2014 to Israel (Luria et al. 2017).ย  This newly emerging virus can infect tomato and pepper plants at any stage of development and greatly affect crop yield and quality. Furthermore, the virus spreads rapidly by mechanical contact but can also be spread over long distances by contaminated seeds (Caruso et al. 2022), and as of 2022 it had been detected in 35 countries across four continents (Zhang et al. 2022).ย  Compounding its transmissibility, is the ability of the virus to escape plant genetic resistance to viral infection (Zhang et al. 2022). There are seven host plants for the virus, including some common grasses and weeds, which could act as a reservoir for the virus, even if it is eliminated from commercial crops. Some researchers consider ToBRFV to be the most serious threat to tomato production in the world.ย 

Continue reading “Automated Sampling and Detection of ToBRFV: An Emerging Tomato Virusย “

Rooted in Resilience: The Future of Pest-Resistant Crops

Sunlight illuminating crops growing in a field

Farmers everywhere strive to protect their crops and ensure a stable food supply while minimizing environmental harm. A promising approach to achieving this leverages a plantโ€™s built-in defense mechanisms, reducing the need for chemical interventions. Many geneticists and agronomists lean on technologies that can automate and streamline nucleic acid extraction and pathogen detection to identify naturally pest resistant crops and, ultimately, keep up with the changing agricultural landscape.ย ย 

Continue reading “Rooted in Resilience: The Future of Pest-Resistant Crops”

Addressing the Problem of Dosing in Gene Therapy

One key obstacle to crafting effective gene therapies is the ability to tailor dosing according to a patientโ€™s needs. This can be tricky because even if protein production is successful, staying within the therapeutic window is paramountโ€”too much of a protein could be toxic, and too little will not produce the desired effect. This balance is difficult to achieve with current technologies. In a study recently published in Nature Biotechnology, researchers at Baylor College of Medicine investigated a possible solution to this problem, engineering a molecular โ€œon/offโ€ switch that could regulate gene expression and maintain protein production at dose-dependent, therapeutic levels.

Continue reading “Addressing the Problem of Dosing in Gene Therapy”